Clinical trials: Hydroxychloroquine, open to volunteers

Aging

Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks

• Enrolling by invitation
• Age: 50 to 100 years
• Early Phase 1

This study tests whether certain medicines and a skin treatment can slow down or partly reverse the body's aging process. As people age, the activity of their genes changes in predictable ways.

Trial name

NCT07888595

Testing

Topical anti-aging peptide serum

Where

United States

Volunteers

48 people, healthy volunteers welcome

Sponsor

Frontiers in Bioscience Research Institute and Aging